Impacts of the Consolidated Appropriations Act 2026 on Healthcare 

Each year, Congress passes a Consolidated Appropriations Act, a large funding package that allocates resources across federal agencies and programs. The Consolidated Appropriations Act 2026 was particularly significant for healthcare because several temporary policies and funding provisions established during the COVID-19 pandemic were approaching expiration. The legislation extended support for key healthcare programs, introduced reforms aimed at increasing transparency in prescription drug pricing, and continued funding for providers serving low-income and underserved populations. Together, these provisions seek to improve healthcare access and affordability for millions of Americans. 

The COVID-19 pandemic transformed healthcare delivery in the United States, accelerating the adoption of telehealth and home-based care. Although these services existed before the pandemic, their utilization increased dramatically during the public health emergency and have remained an important component of healthcare delivery. A study conducted by the U.S. Department of Health and Human Services (HHS) found that telehealth visits among Medicare beneficiaries increased from approximately 840,000 in 2019 to more than 50 million in 2020, representing a substantial expansion in access to remote care (Samson et al., 2021). Hospital-at-home programs have also expanded as an alternative to traditional inpatient hospitalization for selected patients with stable medical conditions. 

Compared with prolonged hospital stays, home-based care may reduce risks associated with hospitalization, including hospital-acquired infections and delirium. Among Medicare beneficiaries, one study found that hospital-at-home care was associated with lower in-hospital mortality and lower emergency department utilization within 30 days of discharge compared with traditional inpatient hospitalization (Vakkalanka et al., 2026). Recognizing the growing role of these services, the Consolidated Appropriations Act of 2026 extended Medicare telehealth flexibilities through December 2027 and continued funding for hospital-at-home programs through 2030. 

The Consolidated Appropriations Act of 2026 also included provisions intended to address prescription drug affordability. Historically, Pharmacy Benefit Managers (PBMs) have often been compensated through arrangements tied to manufacturer rebates. Critics have argued that these arrangements may create incentives to favor higher-priced drugs that generate larger rebates over lower-cost alternatives. Under the 2026 act, PBM compensation in Medicare Part D was restructured so that 100% of rebates from drugs must be passed on to policy holders, and that PBMs could only receive bona fide services fees aligned with fair market value. Supporters of the reform argue that this change may reduce incentives that contribute to higher drug costs and improve alignment between PBM decision-making and patient interests. More broadly, the legislation sought to increase transparency and accountability within the Medicare Part D prescription drug market, with the goal of improving affordability for beneficiaries. 

In addition to these reforms, the Consolidated Appropriations Act of 2026 continued support for healthcare safety-net programs serving vulnerable populations. The legislation provided approximately $4.6 billion in funding for Community Health Centers through the Community Health Center Fund, helping sustain primary care services for millions of low-income patients (KFF, 2026). The act also delayed scheduled reductions in Medicaid Disproportionate Share Hospital (DSH) payments until 2028. DSH funding helps offset financial losses incurred by hospitals that provide care to large numbers of Medicaid beneficiaries and uninsured patients. By postponing these reductions, the legislation sought to preserve the financial stability of hospitals that serve disadvantaged communities and rely heavily on safety-net funding. 

Congress has extended several healthcare programs established or expanded during the COVID-19 pandemic while introducing reforms aimed at improving prescription drug affordability and maintaining support for safety-net providers. By continuing investments in telehealth, home-based care, community health centers, and Medicaid-related funding, the legislation represents an effort to improve healthcare access and affordability. The long-term impact of these policies will depend on their implementation and their effectiveness in addressing persistent challenges related to healthcare costs and health disparities. 

References 

1. Samson, L. W., Tarazi, W., Ramchandani, R., Nguyen, F. X., Dibble, C., Sheingold, S., De Lew, N., & Sommers, B. D. (2021). Medicare beneficiaries’ use of telehealth in 2020: Trends by beneficiary characteristics and location (Issue Brief No. HP-2021-27). Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services. https://aspe.hhs.gov/sites/default/files/documents/a1d5d810fe3433e18b192be42dbf2351/medicare-telehealth-report.pdf  
2. Vakkalanka, J. P., et al. (2026). Outcomes associated with hospital at home vs traditional inpatient stay among Medicare beneficiaries. JAMA Network Open, 9(5), e2610810. https://doi.org/10.1001/jamanetworkopen.2026.10810 
3. KFF. (2026). Community health center patients, financing, and services. Kaiser Family Foundation Health Policy Brief. https://www.kff.org/medicaid/community-health-center-patients-financing-and-services/